Phase I open-label study of the respiratory syncytial virus monoclonal antibody clesrovimab: Safety and tolerability in healthy Chinese participants by Yulei He, Fengli Zhao, Xiao Yang, Shasha Xing, Feifeng Xi, Fen Shen, Lin Yang, Guijun Ning, Fang Sun, Rui Wang, Qiong Shou, Rong Fu, Chang Chen, Anushua Sinha, Xueyan Liao

Get full text